Skip to main content
. 2021 May 20;125(4):576–581. doi: 10.1038/s41416-021-01438-2

Fig. 3. Irradiated tumour progression and survival analyses by TP53 status.

Fig. 3

Irradiated tumour progression by TP53 status in the (a) entire cohort, (b) subset of rhabdomyosarcoma and (c) subset of Ewing sarcoma; (d) distant tumour progression by TP53 status (outside of the irradiated field); and (e) overall survival by TP53 status.